March 3, 2026Open Access

PSMA-guided management of recurrent post-prostatectomy patients: a sub-analysis of a prospective single-center study

Key Points

Management changes occurred in nearly one-third of patients with recurrent prostate cancer, indicating significant implications.
PSMA-PET findings notably influenced radiotherapy strategies and systemic therapy approaches for ongoing cases.
This observational analysis across one center highlights the benefit of targeting management based on PSMA-PET results.
Further validation from randomized trials is necessary to confirm the positive effects on patient outcomes.

Abstract

PSMA-PET led to management changes in nearly one-third of post-prostatectomy recurrent PCa, notably affecting RT strategies and systemic therapy. Emerging evidence suggests that treatment intensification based on PSMA-PET findings may improve patient outcomes compared to de-intensified approaches. The impact on outcomes awaits validation from ongoing prospective randomized trials.

Bookmark

View Full Paper

Cite This Study

Iorio et al. (Thu,) studied this question.

synapsesocial.com/papers/69a75d2dc6e9836116a26c79 https://doi.org/https://doi.org/10.3389/fonc.2026.1764588

Bookmark

View Full Paper